Showing results (91-100 of 123) with videos related to

Sort By:
Pageof 13
American Journal of Clinical Oncology|February 22, 2000
A phase II trial of 5-fluorouracil, leucovorin, and interferon alpha 2A (IFN-alpha 2a) in metastatic pancreatic carcinoma: a Penn Cancer Clinical Trials Group (PCCTG) trialA K David, D J Vaughn, C P Holroyde, et al.
American Journal of Human Genetics|September 14, 2000
Association of HPC2/ELAC2 genotypes and prostate cancerT R Rebbeck, A H Walker, C Zeigler-Johnson, et al.
Urology|April 1, 1996
An analysis of the time course of postoperative prostate-specific antigen failure in patients with positive surgical margins: implications on the use of adjuvant therapyA V D'Amico, R Whittington, S B Malkowicz, et al.
Cancer Research|April 5, 2000
Association of SRD5A2 genotype and pathological characteristics of prostate tumorsJ M Jaffe, S B Malkowicz, A H Walker, et al.
JAMA|January 8, 1997
Development of donor-derived prostate cancer in a recipient following orthotopic heart transplantationE Loh, F J Couch, C Hendricksen, et al.
The Journal of Urology|November 7, 2001
Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen eraA V D'Amico, R Whittington, S B Malkowicz, et al.
Angiology|December 24, 1997
Aortic dissection in a patient receiving chemotherapy for Hodgkin's disease--a case reportM A Golden, D J Vaughn, G W Crooks, et al.
International Journal of Cancer|March 30, 2000
Loss of heterozygosity and tumor suppressor activity of Bin1 in prostate carcinomaK Ge, F Minhas, J Duhadaway, et al.
Urology|September 11, 2001
Estimating the impact on prostate cancer mortality of incorporating prostate-specific antigen testing into screeningA V D'Amico, R Whittington, S B Malkowicz, et al.
Proceedings of Spie--The International Society for Optical Engineering|April 28, 2015
A heterogeneous algorithm for PDT dose optimization for prostateMartin D Altschuler, Timothy C Zhu, Yida Hu, et al.
Pageof 13